FDA Asks Institute Of Medicine To Evaluate 510(k) Review Process
FDA has commissioned the Institute of Medicine to assess its 510(k) pre-market review process for medical devices and help determine how the oft-criticized program can be improved, the agency announced Sept. 23
More from Archive
More from Medtech Insight
A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.